Bloomberg Audio Studios, Podcasts, radio News. The Stock Movers Report, your roundup of companies making moves in the stock market. Harnessing the power of Bloomberg Data.
Let's take a look at some of the stocks on the move today in Europe. I'm Rachel Evans with Caroline Hepka, and we're joined by Bloomberg reporter tiwa Adebio. Spanish natural gas NAGAST has been making gains this morning. Fill us in on what's going on there.
Well, Rachel is one of our equities reporters at Bloomberg has put it this stock is soaring this morning, is up as much as fifteen percent. So Anagas imports stores and transports natural gas. They also operate plants across Spain. And this uptick is a bit of a surprise. It comes after the Spanish regulator unveiled a draft proposal for gas companies, which JP Morgan is saying is unexpectedly positive.
So according to that analyst, you know, under the new proposals, Nagas could benefit from as much as six hundred and fifty million to seven hundred and fifty million euros of incremental revenues. That's just in the first year, So it really does come as a boost to the stock certainly, emits uncertain times for importers and transporters of natural gas like annygas. Is this conflict in the Middle East continues to put pressure on global energy supplies. Yeah.
Absolutely. Meanwhile, a big win for Asenica after a key breakthrough with a drug for lung disease.
That's right, So Astrozenica is near the top of the Eurostock six hundred winners list this morning. It's up just under four percent at the highest and the reason for this is because of one of their experimental drugs. As you mentioned, it's used to treat the deadly lung condition COPD, that's chronic obstructive pulmonary disease. Now, this drug has emerged from two separate studies now with results showing that it
brought statistically significant reductions to flare ups condition. The thinking here from analysts surveyed by Boomberg is that this new development could generate sales of around eight hundred and sixty six million dollars a year by twenty thirty two. And of course these results open up access to a broader, more lucrative market here. But this is a particularly big win for Astrosenica because similar products from its peers like Sanofi and Rosch have disappointed in this area, So potentially
a first mover advantage here. But our Boomberg intelligence analysts are warning to perhaps proceed with caution here because there was a bit of a lack of detail in their original statement about these results, and Astrosenica are still yet to present this and its full findings and an upcoming medical meeting.
Interesting, so the devil could be in the detail there. Meanwhile, we've had some m and A newsed in the alcoholic beverage space tell us more.
So, this still has really been the talk of the industry as far as beverages are concerned. Over the last two days, Perna Recard is reportedly in talks about a potential acquisition of the owners of the firm that creates Jack Daniel's Whiskey, That's Brown Foreman. It's a deal which could create the second biggest player in the US market
according to analysts, so really significant. Shares up as much as four point two percent this morning, but there are questions from some analysts, Deutsche Bank saying they would be surprised if the transaction actually did create material value for shareholders, but some others, like Barclay's, saying it makes strategic sense. So we'll definitely keep monitoring this one as those talks progress, but certainly two very recognizable names within the setup.
The Stock Movers report from Bloomberg Radio. Check back with us throughout the day for the latest roundup of companies making news on Wall Street and for the latest market moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg dot com, and on Applecarplay and Android Auto with the Bloomberg Business app.